Six Blood Molecules Predict Two-Year Survival With 86% Accuracy
Duke Health researchers found six piRNAs in blood outperform age, cholesterol, and activity as survival predictors in older adults.
785 articles
Duke Health researchers found six piRNAs in blood outperform age, cholesterol, and activity as survival predictors in older adults.
Major NIH grants target centenarian genetics and longevity consortia, signaling a new era of federally funded lifespan research.
A Cochrane review of 20,000+ patients finds amyloid-clearing drugs offer no meaningful benefit and raise brain bleed and swelling risks.
A study of 100,000 people found semaglutide users had 44% lower depression risk and 42% fewer psychiatric hospitalizations.
New research reveals both caffeinated and decaf coffee reshape gut microbiome bacteria linked to mood, stress, and cognition.
New NPF primer finds GLP-1 receptor agonists improve psoriasis outcomes and quality of life when added to standard treatments in obese patients.
A study of 1.8 million women reveals stark racial gaps in menopause hormone therapy use, with Black women steered toward off-label drugs.
Amgen expands late-stage testing of its long-acting obesity drug MariTide, including a trial for patients switching from rival GLP-1 medications.
The FDA is piloting live data-streaming in clinical trials, promising faster drug approvals but raising concerns about data quality and bias.
A new DNA-based treatment blocks the PCSK9 protein, cutting LDL cholesterol by nearly 50% while avoiding common statin side effects.
Penn State researchers found abdominal contractions create pressure waves that gently rock the brain, boosting cerebrospinal fluid flow and waste clearance.
Raising Sox9 levels in aging astrocytes reduced amyloid plaque buildup and protected memory in mouse models with existing Alzheimer's symptoms.